Skip to main content
MedicHelpLine
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsORALGeneric

CLEMASTINE FUMARATE

CLEMASTINE FUMARATE

Standard Dose
EQ 0.5MG BASE/5ML
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Discontinued
Summary

Approval overview CLEMASTINE FUMARATE is listed in Drugs@FDA under application 075703 (ANDA).

Marketing status: Discontinued Active ingredient CLEMASTINE FUMARATE Form and strength SYRUP;ORAL - EQ 0.5MG BASE/5ML Sponsor APOTEX INC Submission history Latest submission status date: 2000-11-27 00:00:00.

Structured Monograph

Clinical summary

Approval overview CLEMASTINE FUMARATE is listed in Drugs@FDA under application 075703 (ANDA). Marketing status: Discontinued Active ingredient CLEMASTINE FUMARATE Form and strength SYRUP;ORAL - EQ 0.5MG BASE/5ML Sponsor APOTEX INC Submission history Latest submission status date: 2000-11-27 00:00:00. Submission type: ORIG.

Monitoring

  • Marketing status: Discontinued

Interaction Notes

  • No interaction notes stored yet.